Orexigen Therapeutics Inc (NASDAQ:OREX)

7.54
Delayed Data
As of Apr 17
 -0.26 / -3.33%
Today’s Change
3.11
Today|||52-Week Range
9.37
+24.42%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Turner Heather D
General Counsel, Secretary & Vice President
Sale9/22/2014300,000$4.47$1.3M+67.18%
Turner Heather D
General Counsel, Secretary & Vice President
Buy9/22/2014300,000$1.66$498.0K+67.18%
Booth Mark D
Chief Commercial Officer
Sale2/26/201550,000$5.68$284.0K+28.45%
Narachi Michael A
President & Chief Executive Officer
Buy9/15/201450,000$4.78$239.0K+54.51%
Bock Louis C
Director
Buy11/12/201427,052$5.57$150.7K+29.11%
Turner Heather D
General Counsel & Senior Vice President
Sale11/24/201424,006$5.77$138.5K+28.45%
Turner Heather D
General Counsel & Senior Vice President
Sale12/02/201422,643$6.00$135.9K+25.25%
Booth Mark D
Chief Commercial Officer
Buy2/26/201550,000$1.66$83.0K+28.45%
Turner Heather D
General Counsel & Senior Vice President
Sale11/25/20147,382$6.00$44.3K+30.45%
Turner Heather D
General Counsel & Senior Vice President
Buy11/24/201424,006$1.66$39.8K+28.45%
Page of 3

To view my watchlist

Not a member yet?

Sign up now for a free account